Regulation of uterine immune function during the estrous cycle and in response to infectious bacteria in sheep.
Uterine infections are a major reproductive problem in livestock. We conducted two experiments to investigate factors that may modulate uterine responses to infectious bacteria. In Exp. 1, ewes received intrauterine inoculations of either saline or bacteria (75 x 10(7) cfu of Actinomyces pyogenes and 35 x 10(7) cfu of Escherichia coli) on either d 0 or 7 of the estrous cycle. Vena caval samples containing uteroovarian blood were collected twice daily from 12 h before until 6 d after inoculation. Only ewes inoculated with bacteria on d 7 developed infections. Basal (4.8 vs .4 pmol), lipopolysaccharide-stimulated (14.2 vs 6.1 pmol), and concanavalin A-stimulated (65.8 vs 21.6 pmol) blastogenesis (i.e., [3H]thymidine incorporation) of vena caval lymphocytes was greater (P < or = .002) for ewes inoculated with bacteria or saline on d 0 rather than on d 7. The number (per 100 white blood cells) of lymphocytes was greater (41.3 vs 30.8, P < .001) and that of neutrophils was less (42.5 vs 51.6, P < .001) in ewes inoculated on d 0 rather than d 7. Bacteria increased (P < .05) vena caval PGF(2 alpha) but not PGE2 concentrations. In Exp. 2, two protein fractions (molecular weights of > or = 100 kDa and approximately 12.7 kDa) from chromatography of uterine flushings collected on d 0 or 7, or 18 d after ovariectomy on d 0 or 7, modulated phytohemagglutinin-stimulated blastogenesis; the heavier fraction from d 0 had a stimulatory component, but the major effects of the fractions were inhibitory. The differences in immune function and regulation between d 0 and 7 probably explain how the uterus of follicular phase ewes was able to prevent the development of an infection.
Ramadan
A A
AA
Department of Animal and Poultry Sciences, Virginia Polytechnic Institute, Blacksburg, USA.
Johnson
G L
GL
Lewis
G S
GS
D000190:Actinomyces / Q000276:immunology; D000196:Actinomycosis / Q000276:immunology / Q000503:physiopathology / Q000662:veterinary*; D000818:Animals; D015237:Dinoprost / Q000097:blood; D015232:Dinoprostone / Q000097:blood; D004804:Eosinophils / Q000166:cytology; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000276:immunology / Q000503:physiopathology / Q000662:veterinary*; D004967:Estrogens / Q000097:blood; D004971:Estrus / Q000502:physiology*; D005260:Female; D005498:Follicular Phase / Q000502:physiology; D008183:Luteal Phase / Q000502:physiology; D008213:Lymphocyte Activation / Q000502:physiology; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009000:Monocytes / Q000166:cytology; D009504:Neutrophils / Q000166:cytology; D011374:Progesterone / Q000097:blood; D012756:Sheep / Q000097:blood / Q000276:immunology / Q000502:physiology*; D012757:Sheep Diseases / Q000276:immunology* / Q000503:physiopathology; D013997:Time Factors; D014591:Uterine Diseases / Q000276:immunology / Q000503:physiopathology / Q000662:veterinary*; D014599:Uterus / Q000276:immunology* / Q000378:metabolism / Q000502:physiology
D004967:Estrogens; D011374:Progesterone; D015237:Dinoprost; D015232:Dinoprostone